Cited by 598Protease and Inhibitor MechanismsNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 103 of the 107 references it cites were found in a registry or an index.

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

Rosenberg, Gary A·2009·The Lancet Neurology

DOI 10.1016/s1474-4422(09)70016-x

Open this paper in CoChat — free account

Abstract

Matrix metalloproteinases (MMPs) and proteins containing a disintegrin and metalloproteinase domain (ADAM) are important in neuroinflammation, and recent studies have linked their actions to neurodegenerative disorders. MMPs act as cell-surface sheddases and can affect cell signalling initiated by growth factors or death receptors. Four tissue inhibitors of metalloproteinases (TIMPs) regulate metalloproteinase activity. These proteases increase the permeability of the blood-brain barrier, which can cause oedema, haemorrhage, and cell death. MMPs also participate in tissue repair by promoting angiogenesis and neurogenesis. In vascular cognitive impairment, MMPs change permeability of the blood-brain barrier and might contribute to white matter damage. MMPs and ADAMs might contribute to the formation and degradation of amyloid proteins in Alzheimer's disease and cause death of dopaminergic neurons in Parkinson's disease. In this Review, by examining the effects of neuroinflammation, we try to understand the role that MMPs might have in neurodegenerative diseases. Therapeutic strategies that use inhibitors of MMPs could represent potential novel treatments for neurological diseases.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(09)70016-x

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Tissue inhibitors of metalloproteinases: evolution, structure and function
Brew, K., Dinakarpandian, D., & Nagase, H. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00279-4 · Cited by 1,932
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1106 · Cited by 1,808
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I. E., Bannikov, G. A., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,589
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family.
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
Girouard, H., & Iadecola, C. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00966.2005 · Cited by 1,311
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296

Show all 107 references

Sorted by citations

Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-Pérez, J. M., Evans, A. C., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11934 · Cited by 1,202
The yak genome and adaptation to life at high altitude
Qiu, Q., Zhang, G., Ma, T., Qian, W., Wang, J., Ye, Z., Cao, C., Hu, Q., Kim, J., Larkin, D. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2343 · Cited by 983
The role of macrophage phenotype in vascularization of tissue engineering scaffolds
Spiller, K. L., Anfang, R. R., Spiller, K. J., Ng, J., Nakazawa, K. R., Daulton, J. W., & Vunjak-Novakovic, G. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.012 · Cited by 948
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zloković, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 883
Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease
Yang, Y. R., & Rosenberg, G. A. (2011) · Stroke · doi:10.1161/strokeaha.110.608257 · Cited by 808
Self-citation
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Engaging neuroscience to advance translational research in brain barrier biology
Neuwelt, E. A., Bauer, B., Fahlke, C. M., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O’Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn2995 · Cited by 594
Interactions of Oxidative Stress and Neurovascular Inflammation in the Pathogenesis of Traumatic Brain Injury
Muneer, P. M. A., Chandra, N., & Haorah, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8752-3 · Cited by 476
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
The Infectious Etiology of Alzheimer’s Disease
Sochocka, M., Zwolińska, K., & Leszek, J. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170313122937 · Cited by 399
Microglia and Monocytes/Macrophages Polarization Reveal Novel Therapeutic Mechanism against Stroke
Kanazawa, M., Ninomiya, I., Hatakeyama, M., Takahashi, T., & Shimohata, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102135 · Cited by 405
The Classification of Microglial Activation Phenotypes on Neurodegeneration and Regeneration in Alzheimer’s Disease Brain
Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 412
Hypertension: A Harbinger of Stroke and Dementia
Faraco, G., & Iadecola, C. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01063 · Cited by 367
Review: sporadic cerebral amyloid angiopathy
Attems, J., Jellinger, K., Thal, D. R., & Van Nostrand, W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01137.x · Cited by 371
Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments
Donkin, J. J., & Vink, R. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328337f451 · Cited by 347
Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype: Astrocyte senescence in aging brain
Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M., & Soininen, H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07738.x · Cited by 333
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331
Matrix Metalloproteinase-9 Mediates Hypoxia-Induced Vascular Leakage in the Brain via Tight Junction Rearrangement
Bauer, A. T., Bürgers, H. F., Rabie, T., & Marti, H. H. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.248 · Cited by 325
Function of microglia and macrophages in secondary damage after spinal cord injury
Ren, Y., Zhou, X., & He, X. (2014) · Neural Regeneration Research · doi:10.4103/1673-5374.143423 · Cited by 328
Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases
Cauwe, B., & Opdenakker, G. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.501783 · Cited by 298
Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer’s Disease
Harris, S. A., & Harris, E. A. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142853 · Cited by 279
Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases
Shiomi, T., Lemaître, V., D'Armiento, J. M., & Okada, Y. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02547.x · Cited by 278
Blood-brain barrier permeability abnormalities in vascular cognitive impairment
Taheri, S., Gasparovic, C., Huisa, B. N., Adair, J. C., Edmonds, E., Prestopnik, J., Grossetete, M., Shah, N. J., Wills, J., Qualls, C., et al. (2011) · Stroke · doi:10.1161/strokeaha.110.611731 · Cited by 248
Self-citation
Targeting the neural extracellular matrix in neurological disorders
Soleman, S., Filippov, M. A., Dityatev, A., & Fawcett, J. W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.050 · Cited by 244
Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy
Hartz, A. M. S., Bauer, B., Soldner, E. L. B., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klünemann, H. H., Schuierer, G., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.627562 · Cited by 248
The blood–brain barrier in neurodegenerative disease: a rhetorical perspective
Carvey, P. M., Hendey, B., & Monahan, A. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06319.x · Cited by 260
Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?
Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A., & Jaworski, D. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3467-10.2010 · Cited by 223
Self-citation
Consensus statement for diagnosis of subcortical small vessel disease
Rosenberg, G. A., Wallin, A., Wardlaw, J. M., Markus, H. S., Montaner, J., WOLFSON, L. I., Iadecola, C., Zloković, B. V., Joutel, A., Dichgans, M., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.172 · Cited by 228
Self-citation
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease
Kaiser, D., Weise, G., Möller, K., Scheibe, J., Pösel, C., Baasch, S., Gawlitza, M., Lobsien, D., Diederich, K., Minnerup, J., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0169-8 · Cited by 208
Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases
Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases
Grammas, P., Martinez, J. M., & Miller, B. B. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001918 · Cited by 212
Brain pericytes among cells constituting the blood-brain barrier are highly sensitive to tumor necrosis factor-α, releasing matrix metalloproteinase-9 and migrating in vitro
Takata, F., Dohgu, S., Matsumoto, J., Takahashi, H., Machida, T., Wakigawa, T., Harada, E., Miyaji, H., Koga, M., Nishioku, T., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-106 · Cited by 210
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition
Woo, Y. R., Lim, J., Cho, D., & Park, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091562 · Cited by 198
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system
Verslegers, M., Lemmens, K., Hove, I. V., & Moons, L. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.03.004 · Cited by 202
Multifaceted role of matrix metalloproteinases (MMPs)
Singh, D. K., Srivastava, S. K., Chaudhuri, T. K., & Upadhyay, G. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00019 · Cited by 196
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 198
Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases
Brkić, M., Balusu, S., Wonterghem, E. V., Gorlé, N., Benilova, I., Kremer, A., Hove, I. V., Moons, L., Strooper, B. D., Kanazir, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0006-15.2015 · Cited by 191
Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.
Clark, K. H., Wiley, C. A., & Bradberry, C. W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9334-7 · Cited by 194
Cerebral Microvascular Injury: A Potentially Treatable Endophenotype of Traumatic Brain Injury-Induced Neurodegeneration
Sandsmark, D. K., Bashir, A., Wellington, C. L., & Diaz-Arrastia, R. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.002 · Cited by 180
Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage
Xiao, Z., Liu, W., Mu, Y., Zhang, H., Wang, X., Zhao, C., Chen, J., & Liu, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.572373 · Cited by 182
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Bjerke, M., Zetterberg, H., Edman, Å., Blennow, K., Wallin, A., & Andreasson, U. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110566 · Cited by 180
Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?
Patel, J. P., & Frey, B. N. (2015) · Neural Plasticity · doi:10.1155/2015/708306 · Cited by 186
Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment
Candelario-Jalil, E., Thompson, J., Taheri, S., Grossetete, M., Adair, J. C., Edmonds, E., Prestopnik, J., Wills, J., & Rosenberg, G. A. (2011) · Stroke · doi:10.1161/strokeaha.110.600825 · Cited by 173
Self-citation
Gold-nanoparticle-based biosensors for detection of enzyme activity.
Hutter, E., & Maysinger, D. (2013) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.002 · Cited by 156
Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia
Engelhardt, S., Patkar, S., & Ogunshola, O. O. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12489 · Cited by 168
3D-printed IFN-γ-loading calcium silicate-β-tricalcium phosphate scaffold sequentially activates M1 and M2 polarization of macrophages to promote vascularization of tissue engineering bone
Li, T., Peng, M., Yang, Z., Zhou, X., Deng, Y., Jiang, C., Xiao, M., & Wang, J. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.012 · Cited by 169
Involvement of perineuronal and perisynaptic extracellular matrix in Alzheimer's disease neuropathology
Morawski, M., Brückner, G., Jäger, C., Seeger, G., Matthews, R. T., & Arendt, T. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00557.x · Cited by 157
Tissue-Specific Functional Networks for Prioritizing Phenotype and Disease Genes
Guan, Y., Gorenshteyn, D., Burmeister, M., Wong, A. K., Schimenti, J. C., Handel, M. A., Bult, C. J., Hibbs, M., & Troyanskaya, O. G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002694 · Cited by 155
Multiplexed Homogeneous Assays of Proteolytic Activity Using a Smartphone and Quantum Dots
Petryayeva, E., & Algar, W. R. (2014) · Analytical Chemistry · doi:10.1021/ac500131r · Cited by 155
Blood-brain barrier dysfunction in disorders of the developing brain
Moretti, R., Pansiot, J., Bettati, D., Strazielle, N., Ghersi‐Egea, J., Damante, G., Fleiss, B., Titomanlio, L., & Gressèns, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00040 · Cited by 165
Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release
Zhai, K., Duan, H. Q., Wang, W., Zhao, S., Khan, G. J., Wang, M., Zhang, Y., Thakur, K., Fang, X., Wu, C., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.032 · Cited by 158
Hemoglobin-Induced Oxidative Stress Contributes to Matrix Metalloproteinase Activation and Blood–Brain Barrier Dysfunction in vivo
Katsu, M., Niizuma, K., Yoshioka, H., Okami, N., Sakata, H., & Chan, P. H. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.45 · Cited by 151
Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons
Abraham, H. M. A., WOLFSON, L. I., Moscufo, N., Guttmann, C. R. G., Kaplan, R. F., & White, W. B. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.121 · Cited by 151
Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9
Hernandez-Guillamon, M., Mawhirt, S., Blais, S., Montaner, J., Neubert, T. A., Rostagno, A., & Ghiso, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610931 · Cited by 137
The Neurovascular Unit Dysfunction in Alzheimer’s Disease
Soto-Rojas, L. O., Pacheco‐Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 146
Mechanobiology of the brain in ageing and Alzheimer's disease
Hall, C. M., Moeendarbary, E., & Sheridan, G. K. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14766 · Cited by 140
Blood–brain barrier and traumatic brain injury
Alves, J. L. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23300 · Cited by 139
Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: Mechanisms and possible interventions
Li, Y., Gonzalez, P., & Zhang, L. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.010 · Cited by 135
The barrier and interface mechanisms of the brain barrier, and brain drug delivery
Zhang, S., Gan, L., Cao, F., Wang, H., Gong, P., Ma, C., Ren, L., Lin, Y., & Lin, X. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.09.017 · Cited by 129
Matrix Metalloproteinase-2 and Metalloproteinase-9 Activities are Associated with Blood–Brain Barrier Dysfunction in an Animal Model of Severe Sepsis
Dal‐Pizzol, F., Rojas, H. A., dos Santos, E. M., Vuolo, F. S., Constantino, L. D. S., Feier, G., Pasquali, M. A. D. B., Comim, C. M., Petronilho, F. C., Gelain, D. P., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8433-7 · Cited by 132
Hypoxia-Induced Neuroinflammatory White-Matter Injury Reduced by Minocycline in SHR/SP
Jalal, F. Y., Yang, Y. R., Thompson, J. F., Roitbak, T., & Rosenberg, G. A. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.21 · Cited by 121
Self-citation
Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia
Cui, J., Chen, S., Zhang, C., Meng, F., Wu, W., Hu, R., Hadass, O., Lehmidi, T. E., Blair, G. J., Lee, M., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-21 · Cited by 123
The impact of pericytes on the blood–brain barrier integrity depends critically on the pericyte differentiation stage
Thanabalasundaram, G., Schneidewind, J., Pieper, C., & Galla, H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.05.002 · Cited by 125
Update of human and mouse matrix metalloproteinase families
Jackson, B. C., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-4-3-194 · Cited by 119
Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury
Hadass, O., Tomlinson, B. N., Gooyit, M., Chen, S., Purdy, J. J., Walker, J. M., Zhang, C., Giritharan, A. B., Purnell, W., Robinson, C. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076904 · Cited by 120
Inflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease
de Vries, H. E., Kooij, G., Frenkel, D., Georgopoulos, S., Monsonego, A., & Janigro, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03702.x · Cited by 116
Matrix metalloproteinase‐3 in the central nervous system: a look on the bright side
Hove, I. V., Lemmens, K., de Velde, S. V., Verslegers, M., & Moons, L. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07900.x · Cited by 113
Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation
Conant, K. E., Wang, Y., Szklarczyk, A., Dudak, A., Mattson, M. P., & Lim, S. T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.061 · Cited by 116
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Kim, S., Jung, U. J., & Kim, S. R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14020386 · Cited by 129
Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice
Ma, X., Jiang, Y., Wu, A., Chen, X., Pi, R., Liu, M., & Liu, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013489 · Cited by 110
New strategies for targeting matrix metalloproteinases.
Fields, G. B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.002 · Cited by 98
Anti-Inflammatory and Antioxidant Mechanism of Tangeretin in Activated Microglia
Lee, Y. Y., Lee, E.-J., Park, J., Jang, S., Kim, D., & Kim, H.-S. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9657-x · Cited by 108
Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats
Kanazawa, M., Miura, M., Toriyabe, M., Koyama, M., Hatakeyama, M., Ishikawa, M., Nakajima, T., Onodera, O., Takahashi, T., Nishizawa, M., et al. (2017) · Scientific Reports · doi:10.1038/srep42582 · Cited by 106
Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections
Geurts, N., Opdenakker, G., & den Steen, P. E. V. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.008 · Cited by 105
Matrix Metalloproteinase 9 in Epilepsy: The Role of Neuroinflammation in Seizure Development
Bronisz, E., & Kurkowska‐Jastrzębska, I. (2016) · Mediators of Inflammation · doi:10.1155/2016/7369020 · Cited by 108
Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease
Stomrud, E., Björkqvist, M., Janciauskiene, S. M., Minthon, L., & Hansson, O. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt44 · Cited by 107
Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood–brain barrier model
Labus, J., Häckel, S., Lucka, L., & Danker, K. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.03.002 · Cited by 104
MMPs in the Trabecular Meshwork: Promising Targets for Future Glaucoma Therapies?
Groef, L. D., Hove, I. V., Dekeyster, E., Stalmans, I., & Moons, L. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13088 · Cited by 104
Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways
Ranaivo, H. R., Hodge, J. N., Choi, N., & Wainwright, M. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-68 · Cited by 108
Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia
Weekman, E. M., & Wilcock, D. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150759 · Cited by 106
Relations of Blood Inflammatory Marker Levels With Cerebral Microbleeds
Miwa, K., Tanaka, M. R., Okazaki, S., Furukado, S., Sakaguchi, M., & Kitagawa, K. (2011) · Stroke · doi:10.1161/strokeaha.111.621193 · Cited by 99
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
Stukas, S. K., Robert, J., & Wellington, C. L. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.003 · Cited by 101
The Blood–Brain Barrier and Its Intercellular Junctions in Age-Related Brain Disorders
Costea, L., Mészáros, Á., Bauer, H., Bauer, H., Traweger, A., Wilhelm, I., Farkas, A. E., & Krizbai, I. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215472 · Cited by 102
MMP-9, a Potential Target for Cerebral Ischemic Treatment
Dong, X., Song, Y., Liu, W., & Guo, X. (2009) · Current Neuropharmacology · doi:10.2174/157015909790031157 · Cited by 102
Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood–brain barrier and glioma cells
Andresen, T. L., Bruun, J., Larsen, T. B., Jølck, R. I., Eliasen, R., Holm, R., & Gjetting, T. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s87334 · Cited by 98
Biomimetic Approaches for Bone Tissue Engineering
Ng, J., Spiller, K. L., Bernhard, J., & Vunjak‐Novakovic, G. (2016) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2016.0289 · Cited by 100
Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges
Zipfel, P., Rochais, C., Baranger, K., Rivera, S., & Dallemagne, P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00352 · Cited by 94
Recent Updates on Subcortical Ischemic Vascular Dementia
Roh, J. H., & Lee, J.-H. (2014) · Journal of Stroke · doi:10.5853/jos.2014.16.1.18 · Cited by 93
Smoking and Endothelial Dysfunction
Golbidi, S., Edvinsson, L. I., & Laher, I. (2018) · Current Vascular Pharmacology · doi:10.2174/1573403x14666180913120015 · Cited by 97
A New Face for Old Antibiotics: Tetracyclines in Treatment of Amyloidoses
Stoilova, T., Colombo, L., Forloni, G., Tagliavini, F., & Salmona, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400161p · Cited by 97
Intrathecal Delivery of Mesenchymal Stromal Cells Protects the Structure of Altered Perineuronal Nets in SOD1 Rats and Amends the Course of ALS
Forostyak, S., Homola, A., Turnovcová, K., Svítil, P., Jendelová, P., & Syková, E. (2014) · Stem Cells · doi:10.1002/stem.1812 · Cited by 92
Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
Niebrój-Dobosz, I., Janik, P., Sokołowska, B., & Kwieciński, H. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02775.x · Cited by 96
β-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia
Lee, E.-J., Ko, H.-M., Jeong, Y.-H., Park, E.-M., & Kim, H.-S. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0355-z · Cited by 91
Matrix Metalloproteinase-8 Plays a Pivotal Role in Neuroinflammation by Modulating TNF-α Activation
Lee, E.-J., Han, J. E., Woo, M.-S., Shin, J. A., Park, E., Kang, J. L., Moon, P. G., Baek, M., Son, W.-S., Ko, Y. T., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303240 · Cited by 91
Tanshinone IIA reduces the risk of Alzheimer’s disease by inhibiting iNOS, MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer’s disease
JIANG, P., Li, C., Xiang, Z., & Jiao, B. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2254 · Cited by 89
Proteolytic cleavage of proBDNF to mBDNF in neuropsychiatric and neurodegenerative diseases
Wang, M., Xie, Y., & Qin, D. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.11.005 · Cited by 97
Matrix metalloproteinases in Alzheimer’s disease and concurrent cerebral microbleeds.
Duits, F. H., Hernandez-Guillamon, M., Montaner, J., Goos, J. D. C., Montañola, A., Wattjes, M. P., Barkhof, F., Scheltens, P., Teunissen, C. E., & van der Flier, W. M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143186 · Cited by 92

Authors: Rosenberg, G. A.
Affiliations: University of New Mexico (US)
Corresponding author: Rosenberg, Gary A
ORCID: Rosenberg, Gary A
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2009-02
Volume: 8
Issue: 2
Pages: 205-216
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(09)70016-x
OpenAlex: W2124054487
Cited by: 594
References: 107
Citations by year: 2026: 27 · 2025: 23 · 2024: 18 · 2023: 34 · 2022: 33 · 2021: 35 · 2020: 29 · 2019: 28 · 2018: 22 · 2017: 34 · 2016: 33 · 2015: 52 · 2014: 54 · 2013: 47 · 2012: 37
FWCI: 2.62
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R01NS045847, R01NS052305)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: matrix metalloproteinases, ADAMS, neuroinflammation, neurodegenerative diseases, blood-brain barrier permeability, tissue inhibitors of metalloproteinases, matrix metalloproteinase inhibitors, Alzheimer's disease, amyloid, Parkinson's disease, dopaminergic neurons, vascular cognitive impairment, white matter injury, angiogenesis, neurogenesis, signal transduction
MeSH terms: Humans, Inflammation, Protease Inhibitors, Neurodegenerative Diseases, Matrix Metalloproteinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks